# Ballot Battles and Legislative Wins: Cannabis Politics Heat Up Across America
Florida's cannabis legalization effort just hit a dead end. According to Marijuana Moment, the Florida Supreme Court rejected a campaign's appeal to restore tens of thousands of rejected signatures for a legalization initiative, effectively killing any chance of getting it on the 2026 ballot. Meanwhile, Oklahoma's governor is doubling down. Gov. Kevin Stitt claims lawmakers support his push to roll back the state's voter-approved medical marijuana law, arguing that Oklahomans were "sold a bill of goods" in 2018—even though Stitt himself admits the state now has more dispensaries than pharmacies, suggesting the law is actually working exactly as intended for patients who need it. [DOUBLE STANDARD WATCH] It's telling that a governor can claim voters were deceived about a product they actively chose to legalize, while simultaneously defending alcohol and tobacco—substances that kill tens of thousands of Americans annually—as acceptable for anyone to buy at any convenience store. The irony isn't lost on anyone paying attention.
But not every state is moving backward. Tennessee lawmakers just relaunched their "Pot for Potholes" campaign, as reported by Forbes, proposing to legalize recreational cannabis and use the tax revenue to fix roads. Georgia's House passed a bill with broad bipartisan support to modernize its medical cannabis program, according to the Georgia Recorder. And Minnesota lawmakers approved psilocybin therapy legalization, as Marijuana Moment reported—creating a regulated program for adults 21 and older under the supervision of trained facilitators. Colorado sent Gov. Jared Polis a bill allowing terminally ill patients to use medical cannabis in hospitals. The landscape is shifting, state by state, regardless of what the federal government says.
🚀 THIS IS COOL New science is backing up what patients already know. According to the articles, a new study published by the American Medical Association found that a single psilocybin dose combined with cognitive behavioral therapy yielded significantly greater results for treating certain conditions. Hawaii's Senate passed a bill to create a psychedelics task force to study pathways to access psilocybin and MDMA. And a Columbia University study reported by Medical Xpress found that adopting recreational cannabis laws—beyond just medical—may help reduce the size of illegal cannabis markets. This is the opposite of what prohibition promises. Legal access actually shrinks the black market. Why? Because people prefer buying from regulated sources when given the choice, not because cannabis use magically disappears when it's banned.
Here's where things get legally messy: the 9th Circuit Court of Appeals just ruled that the Dormant Commerce Clause does not apply to cannabis, according to Reuters, sparking a circuit split on the question. That means different federal courts now interpret cannabis commerce law differently—a situation that screams for federal action to clarify what the rules actually are. Meanwhile, Sen. Jeff Merkley introduced an amendment that would let cannabis industry workers qualify for federally backed mortgage loans by treating cannabis income the same as income from other industries, as Marijuana Moment reported. 💰 MONEY MOVES This matters because thousands of people work in a legal industry but can't access basic financial services. A federal government that says cannabis is legal enough to tax but not legitimate enough to finance is, frankly, playing games with people's lives.
Not everything is progress, though. Arizona passed a bill to punish people for creating "excessive" marijuana smoke or odor, punishable by up to four months in jail, as Marijuana Moment reported—a measure advocates say amounts to overreach beyond what voters envisioned when they legalized the plant. And in New Hampshire, the House let bills to legalize marijuana and allow psilocybin therapy die without even a floor vote, according to Marijuana Moment. Idaho represents perhaps the most troubling pattern: voters would almost certainly pass medical marijuana legalization if allowed to vote on it, as the Pacific Northwest Inlander reported, but conservative lawmakers have deliberately made the ballot initiative process harder by requiring signatures from 18 of 35 legislative districts—essentially gerrymandering democracy itself.
🤔 THINK ABOUT IT This is the real battle now. It's not whether voters support cannabis normalization in most states—polling consistently shows they do. It's whether legislatures will let them vote on it. When politicians can simply block ballot measures from reaching voters, when workers can't get mortgages for legal work, when two states over the same plant is completely legal but here it gets you jail time—we're not dealing with a policy debate anymore. We're dealing with a system rigged to delay inevitable change. The question isn't whether America normalizes cannabis. The question is how many more years we waste before we admit what voters, science, and basic fairness already know: cannabis belongs in the same conversation as alcohol and coffee, not locked behind fear and gatekeeping. Your move, Congress.
# Hemp Ban Watch: Texas Burns Down a $10 Billion Industry in Three Weeks
Texas is about to torch a $10-12 billion hemp marketplace in the span of 72 hours. Starting March 31, smokable hemp products—the joint, the blunt, the flower that's been flying off shelves since 2019—will become illegal across the state. The Texas Department of State Health Services finalized the rules on March 6, and according to reporting from Yahoo News and the Dallas Observer, what looked like a regulatory adjustment is actually a death sentence for thousands of small businesses. "You're talking about shuttering stores that employ over 50,000 Texans," Mark Bordas, executive director of the Texas Hemp Business Council, told reporters. 💰 MONEY MOVES The state is betting that raising licensing fees to $5,000 annually for retailers and $10,000 for manufacturers will somehow offset the economic devastation—a calculation that makes zero sense when store owners are bracing for 60-70% revenue declines overnight.
Here's where it gets interesting: this wasn't a legislative victory. Back in the 2025 session, lawmakers voted to ban hemp-derived THC entirely, but Governor Greg Abbott vetoed the ban outright. Instead of accepting defeat, the state's health department found a workaround through an executive order by tweaking how THC is measured. Previously, the legal standard was simple—0.3% delta-9 THC by dry weight, the compound that actually gets you high. The new rules shift to measuring total THC content, which includes THCA, a non-psychoactive cannabinoid that converts to delta-9 at an 88% rate when you smoke it. As the Dallas Observer explained, almost no hemp flower can survive this total THC standard—effectively banning the product through administrative process rather than honest legislation. One anonymous hemp shop operator told Yahoo News: "For many small retailers across Texas—including my own vape shop—these rules will effectively shut down our businesses overnight."
The hemp industry saw this coming and fought back hard during the public comment window. But the state wasn't interested in compromise. What's wild is that the rules will ban smokable hemp flower and extracts while leaving hemp-derived edibles and drinks untouched. Nicholas Mortillaro, a hemp store operator, pointed out the absurdity: smokable hemp is the most commonly ordered product in Texas, meaning retailers are losing their bread and butter while edibles—which arguably pose more consumer control issues—remain perfectly legal. [DOUBLE STANDARD WATCH] "Cannabis remains Schedule I while alcohol—responsible for 95,000 deaths per year—is advertised during the Super Bowl. Something doesn't add up." Yet here's Texas banning a zero-overdose product while the state literally taxes alcohol sales. If the goal is consumer protection, why shut down tested, regulated smokable products and expect people to turn to untested black-market alternatives? Heather Fazio, director of the Texas Cannabis Policy Center, spelled out exactly what's going to happen: "Effectively, this is going to ban hemp flower from the legal marketplace. Consumers enjoy the natural product with naturally occurring levels of THC in the hemp flower, and changing to these unreasonably restrictive testing standards would push this marketplace underground, handing it over to illicit operators because legitimate businesses can no longer sell it."
But Texas isn't the only state tightening the noose. Ohio is preparing its own hemp ban, with CBD stores and breweries facing an uncertain future as reported by the Columbus Dispatch. South Carolina is now polling residents on whether to ban intoxicating hemp products entirely, according to The State Columbia. This is a coordinated wave, not a fluke—and it's happening while federal lawmakers are also considering a sweeping national ban. The hemp industry exploded after the 2018 Farm Bill created a loophole for products containing less than 0.3% delta-9 THC. For seven years, it thrived in a gray zone. Now that zone is collapsing state by state, store by store. 💰 MONEY MOVES The industry was generating north of $10 billion annually in Texas alone. By April 1, that revenue disappears into the black market, the tax base shrinks, and 50,000 jobs face elimination. Who benefits? Illegal operators and the people who never wanted legal hemp to exist in the first place.
🤔 THINK ABOUT IT Texas is banning a plant product with zero recorded overdose deaths in human history—a plant that helps veterans manage PTSD, chronic pain, and insomnia—while leaving alcohol and prescription opioids on every shelf and in every medicine cabinet. The same state that claims to protect children does nothing about alcohol, which kills more teenagers than any other drug-related substance. These rules take effect in three weeks. After that, Texans who were buying legal, tested hemp flower will either quit the product entirely or find their way to unregulated dealers. The state calls this consumer protection. Most rational observers call it exactly what it is: prohibition wearing a regulatory disguise.
# THC in Science: Cannabis Compounds Show Therapeutic Promise While Questions Mount About Memory and Safety
Cannabis science is accelerating in directions that challenge decades of assumptions about the plant. This week alone, research from institutions across the globe reveals both remarkable therapeutic potential and cognitive risks that deserve serious attention—while raising an uncomfortable question about why policy consistently lags behind what the evidence actually shows.
🚀 THIS IS COOL Researchers at the Hebrew University of Jerusalem have identified a mechanism by which cannabis compounds CBD and CBG could reverse metabolic dysfunction-associated steatotic liver disease (MASLD), a condition affecting roughly one-third of the global adult population. According to the study published in the British Journal of Pharmacology, these non-psychoactive compounds trigger a "metabolic remodeling" process that increases phosphocreatine levels and enhances the liver's ability to clean out harmful toxins. Meanwhile, Italian researchers reporting in Phytomedicine found that intranasal cannabis essential oil reduced pain, improved mobility, and eased anxiety and depression-like symptoms in multiple sclerosis models by activating the CB2 receptor—a pathway that appears to protect nerve tissue without producing intoxication. At the University of Otago in Wellington, medicinal cannabis showed measurable benefits for endometriosis and pelvic pain, improving sleep and lowering anxiety in patients with a condition that affects millions. These are not fringe findings; they're appearing in peer-reviewed journals and tracking real therapeutic mechanisms. Yet the federal government still classifies cannabis as Schedule I—meaning it has "no currently accepted medical use"—a classification that actively obstructs the very research these breakthroughs represent.
But science cuts both ways, and researchers at Washington State University have published findings that demand honest conversation. 🚀 THIS IS COOL Their study in the Journal of Psychopharmacology, the most comprehensive examination of THC's effects on memory to date, shows something unsettling: THC doesn't just blur memories—it creates false ones. In controlled experiments, cannabis users were significantly more likely to recall words that were never shown to them and struggled with everyday memory tasks like remembering appointments or conversations. The findings affected 15 of 21 memory measures tested, and shockingly, moderate doses of 20 milligrams produced memory disruption similar to 40-milligram doses. This matters. If you're using cannabis regularly, you may not just be forgetting things; you may be confidently remembering things that never happened. That's the kind of side effect users deserve to know about—and it's the kind of finding that should shape how we talk about cannabis use, especially for aging populations.
Speaking of older adults, Medicare is about to wade into uncharted territory. MarketWatch reported that a proposal expected to begin in April 2026 would provide Medicare beneficiaries up to $500 annually to purchase CBD products, framed as an alternative to opioids and benzodiazepines for chronic pain, sleep disorders, and anxiety. The intent is reasonable—reducing reliance on pharmaceuticals that kill thousands of Americans every year—but the execution raises questions. 💰 MONEY MOVES This program could reshape the senior health market, creating a new revenue stream for cannabis companies while enrolling millions of older Americans in what amounts to real-world testing. A study from the Journal of Pain Research offers some reassurance: among patients 65 and older, CBD-dominant full-spectrum extracts outperformed pure THC, producing greater pain relief with far fewer side effects. Patients on CBD-dominant products reported 104 adverse reactions versus 342 in the THC group, and only 5.6% discontinued due to side effects compared to 19.2% in the THC group. But here's the tension: if we're confident enough to offer this to millions of seniors, why are we still blocking the research that would tell us exactly how it works and for whom it works best?
Quality control is another problem nobody's talking about loudly enough. Medical Xpress reported that delta-8 THC products—marketed as "legal cannabis" and increasingly coming in youth-oriented packaging—show inconsistent labeling and dangerously high doses. These products spike in popularity precisely because of legal gray areas created by federal prohibition. [DOUBLE STANDARD WATCH] We allow alcohol—which kills approximately 95,000 Americans per year—to be sold with strict labeling requirements and age restrictions in every grocery store and gas station in America. Cannabis, which has never caused a recorded overdose death, remains so legally murky that unregulated delta-8 products end up in convenience stores with no quality standards at all. The prohibition itself creates the very market failures it claims to prevent. A Columbia University study found that adopting recreational cannabis laws, beyond just medical cannabis laws, actually helps reduce illegal cannabis markets in U.S. states. Legalization works. Prohibition breeds chaos.
The mental health question also demands honesty. Research from McMaster University published in The Canadian Journal of Psychiatry found that THC use correlates with increased rates of anxiety and depressive disorders—though correlation doesn't prove causation, and the direction of the relationship remains unclear. Do people use cannabis because they're struggling with anxiety, or does cannabis trigger it? The science hasn't fully untangled that. What we know is that CBD appears to have opposite effects, suggesting the plant's different compounds affect the brain in fundamentally different ways. This is exactly the kind of nuance that disappears when cannabis remains Schedule I and researchers can't access the funding or legal infrastructure needed to conduct properly controlled human trials.
🤔 THINK ABOUT IT Here's what this week's research actually tells us: cannabis contains compounds with genuine therapeutic applications for liver disease, multiple sclerosis, chronic pain, and endometriosis. It also contains THC, which can disrupt memory formation and may correlate with mental health risks—the same way alcohol is both culturally acceptable and linked to liver disease, accidents, and addiction. The difference is we study alcohol openly, regulate it transparently, and let adults make informed choices. We don't arrest people for using it. We don't classify it as having "no medical use." We don't block researchers from studying it. Alcohol kills tens of thousands of Americans annually. Cannabis kills zero. So why are we still treating one like medicine and the other like a Schedule I narcotic? The science has moved on. The policy hasn't. And the longer we wait, the more people make choices based on incomplete information instead of the facts that are already there.
Texas is about to wipe out a multibillion-dollar industry in less than three weeks. On March 31, the state's hemp market will effectively collapse when new regulations banning smokable cannabis products take effect—and the ripple effects are already reshaping the landscape for thousands of businesses and hundreds of thousands of workers across the state.
The Texas Department of State Health Services finalized the rules last week, and here's what's actually happening: the state is changing how it measures THC content. Instead of testing only for Delta-9 THC (the primary psychoactive compound), regulators will now measure "total THC," which includes THCA—a non-psychoactive cannabinoid that converts to Delta-9 at roughly an 88% rate when heated. According to Marijuana Moment, this definitional shift was recommended by Governor Greg Abbott's executive order last September, after the legislature deadlocked over whether to regulate or ban hemp products entirely. The result? Almost all smokable hemp flower—the most commonly ordered product in Texas shops—will become non-compliant overnight. Edibles and infused drinks escape the ban, but flower and extracts are done.
Here's the economic reality: 💰 MONEY MOVES Retailers and manufacturers face sharply higher licensing fees starting immediately. As reported by The Business Journals, retail shops now pay $5,000 annually (up from $150), while manufacturers pay $10,000 per facility (up from $250). These fees were reduced from initial proposals—the Texas Cannabis Policy Center celebrated that victory—but the damage is done. According to Yahoo News, Mark Bordas, executive director of the Texas Hemp Business Council, warned that the state is "shuttering stores that employ over 50,000 Texans" and disrupting "an industry that generates over $10-12 billion a year." One hemp store operator told the outlet he expects 60-70% revenue declines within three weeks. Some retailers say they'll have to close entirely.
This is where the contradiction gets impossible to ignore. [DOUBLE STANDARD WATCH] Cannabis remains Schedule I—meaning the federal government classifies it as having "no accepted medical use" and high abuse potential—while alcohol kills roughly 95,000 Americans per year and is sold in every grocery store, gas station, and convenience store in Texas. Yet here we are, banning a product with zero recorded overdose deaths in human history because it's "intoxicating." Meanwhile, according to The Texas Tribune, local and federal law enforcement have conducted more than 15 raids on hemp businesses since August 2024—seizing assets, freezing cash, and devastating operations without formal charges. One attorney noted that "you always see the headlines about the raids, but you never see huge headlines about charges and indictments." Police say raids are necessary to root out illegal products. But the pattern suggests something else: enforcement agencies justifying increasingly aggressive action against a legal industry selling a product that hasn't killed a single person.
What makes this particularly painful is that the ban will almost certainly hand market share back to illicit operators. Heather Fazio, director of the Texas Cannabis Policy Center, told Marijuana Moment that "this will hand 50 percent of the legal market to illicit operators, making our state less safe." Think about that: regulators are creating the exact conditions that push consumers toward untested, unregulated products sold by people with no compliance infrastructure, no lab testing, no consumer protections. The irony is so thick you can taste it. Meanwhile, 🚀 THIS IS COOL—Texas's medical cannabis program is actually expanding. According to Marijuana Moment, nine new medical marijuana licenses have already been approved with three more expected before April 1. So the state trusts regulated medical cannabis enough to expand it, but not hemp. The inconsistency reveals what's really driving this: not safety science, but selective enforcement.
🤔 THINK ABOUT IT If your goal is to protect public health and keep people safe, why would you ban a legal product with zero overdose deaths while allowing the substance that kills nearly 100,000 Americans per year to remain unrestricted? Why would you create conditions that push consumers from regulated markets into unregulated ones? Why would you destroy 50,000 jobs in a $10-12 billion industry without presenting evidence that the product itself poses measurable harm? These aren't rhetorical questions—they're the questions Texas should be asking itself right now, before March 31 arrives and the consequences become permanent.
